肌少症疾病动物模型的研究进展*

马晴宇 ,  孙岩 ,  王越晖 ,  董晗

国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (6) : 597 -599.

PDF (1166KB)
国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (6) : 597 -599. DOI: 10.3969/j.issn.1674-7593.2026.06.015
综述

肌少症疾病动物模型的研究进展*

作者信息 +

Research progress on sarcopenia animal models

Author information +
文章历史 +
PDF (1193K)

摘要

肌少症是一种与年龄增长相关的骨骼肌退行性疾病, 以肌肉质量、 力量和功能进行性 丧失为特征表现, 严重影响老年人的生活质量与寿命。 疾病动物模型对研究肌少症发病机制及揭示新治 疗靶点均具有十分重要的指导意义。 本文对常用的小鼠与斑马鱼肌少症动物模型的构建原理、 适用条件 及局限性作一综述, 为优化肌少症疾病动物模型的构建与研究提供参考。

Abstract

Sarcopenia is an age-related degenerative disease of skeletal muscle, characterized by the progressive loss of muscle mass, muscle strength, and physical function, which seriously compromises the quality of life and life expectancy of the elderly. Animal models of sarcopenia serve as crucial research tools for exploring the pathogenesis and identifying novel therapeutic targets. This review summarizes the construction principles, applicable conditions, advantages, and limitations of commonly used sarcopenia animal models based on mice and zebrafish, aiming to provide valuable references for the optimization and further application of sarcopenia animal models.

关键词

肌少症 / 发病机制 / 动物模型 / 小鼠模型 / 斑马鱼模型

Key words

Sarcopenia / Pathogenesis / Animal models / Mouse models / Zebrafish models

引用本文

引用格式 ▾
马晴宇,孙岩,王越晖,董晗. 肌少症疾病动物模型的研究进展*[J]. 国际老年医学杂志, 2026, 47(6): 597-599 DOI:10.3969/j.issn.1674-7593.2026.06.015

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Yuan S, Larsson S C . Epidemiology of sarcopenia: prevalence, risk factors, and consequences[J]. Metabolism, 2023, 144: 155533.

[2]

Liu L, Zhang Y, Shi Y, et al. The bidirectional relationship between sarcopenia and disability in China: a longitudinal study from CHARLS [J]. Front Public Health, 2024, 12: 1309673.

[3]

Christian C J, Benian G M . Animal models of sarcopenia [J]. Aging Cell, 2020, 19(10): e13223.

[4]

Xie W Q, He M, Yu D J, et al. Mouse models of sarcopenia: classification and evaluation [J]. J Cachexia Sarcopenia Muscle, 2021, 12(3): 538-554.

[5]

黄鑫尘, 陈佳鑫, 黎思雨, 等. 肌肉减少症鼠类动物模型评估方法的研究进展[J]. 放射学实践, 2024, 39(5): 689-693.

[6]

Huang X C, Chen J X, Li S Y, et al. Research progress on evaluation methods of sarcopenia rat animal model [J]. Radiol Pract, 2024, 39(5): 689-693.

[7]

Wei W, Wang S, Hou D, et al. Methods and research progress in the construction of animal models of osteosarcopenia: a scoping review[J]. Front Endocrinol, 2023, 14: 1228937.

[8]

Matsuzaki R, Matsuoka T, Nakanishi K, et al. Effects of green tea catechins and exercise on age-related muscle atrophy and satellite cell functions in a mouse model of sarcopenia[J]. Exp Gerontol, 2025, 202: 112720.

[9]

Huang Y, Wu B, Shen D, et al. Ferroptosis in a sarcopenia model of senescence accelerated mouse prone 8 (SAMP8)[J]. Int J Biol Sci, 2021, 17(1): 151-162.

[10]

Kutz L, Zhou T, Chen Q, et al. A surgical approach to hindlimb suspension: a mouse model of disuse-induced atrophy[J]. Methods Mol Biol, 2023, 2597: 1-9.

[11]

薛慧敏, 宁婧鑫, 李霞, 等. 谷氨酰胺合成酶上调促发模拟失重小鼠骨骼肌萎缩的分子机制[J]. 延安大学学报(医学科学版), 2025, 23(2): 18-23.

[12]

Xue H M, Ning J X, Li X, et al. Upregulation of glutamate-ammonia ligase promotes skeletal muscle atrophy in mice simulating weightlessness[J]. J Yan'an Univ Med Sci, 2025, 23(2): 18-23.

[13]

Rowan S L, Rygiel K, Purves-Smith F M, et al. Denervation causes fiber atrophy and myosin heavy chain co-expression in senescent skeletal muscle [J]. PLoS One, 2012, 7(1): e29082.

[14]

Kinoshita H, Orita S, Inage K, et al. Skeletal muscle cell oxidative stress as a possible therapeutic target in a denervation-induced experimental sarcopenic model[J]. Spine, 2019, 44(8): E446-E455.

[15]

Wang B Y, Hsiao A W, Wong N, et al. Is dexamethasone-induced muscle atrophy an alternative model for naturally aged sarcopenia model? [J]. J Orthop Transl, 2023, 39: 12-20.

[16]

王安彦, 王红梅. 肌少症动物模型的造模方法研究进展[J]. 中华老年多器官疾病杂志, 2024, 23(1): 72-76.

[17]

Wang A Y, Wang H M. Research progress in animal models of sarcopenia[J]. Chin J Mult Organ Dis Elder, 2024, 23(1): 72-76.

[18]

杨璇, 王玉波, 于佳. 肌少症动物模型研究进展[J]. 脑与神经疾病杂志, 2022, 30(5): 328-330, F0003, 324.

[19]

Yang X, Wang Y B, Yu J. Research progress of animal models of sarcopenia[J]. J Brain Nerv Dis, 2022, 30(5): 328-330, F0003, 324.

[20]

Baek K W, Jung Y K, Park J S, et al. Two types of mouse models for sarcopenia research: senescence acceleration and genetic modification models [J]. J Bone Metab, 2021, 28(3): 179-191.

[21]

Nguyen H V, Ran Q, Salmon A B, et al. Mouse models used to test the role of reactive oxygen species in aging and age-related chronic diseases [J]. Free Radic Biol Med, 2024, 225: 617-629.

[22]

Agoncillo M, Yu J, Gunton J E . The role of vitamin D in skeletal muscle repair and regeneration in animal models and humans: a systematic review[J]. Nutrients, 2023, 15(20): 4377.

[23]

Englund D A, Jolliffe A, Aversa Z, et al. p21 induces a senescence program and skeletal muscle dysfunction[J]. Mol Metab, 2023, 67: 101652.

[24]

Mayakrishnan V, Kannappan P, Balakarthikeyan J, et al. Rodent model intervention for prevention and optimal management of sarcopenia: a systematic review on the beneficial effects of nutrients & non-nutrients and exercise to improve skeletal muscle health[J]. Ageing Res Rev, 2024, 102: 102543.

[25]

Callegari S, Mirzaei F, Agbaria L, et al. Zebrafish as an emerging model for sarcopenia: considerations, current insights, and future directions[J]. Int J Mol Sci, 2023, 24(23): 17018.

[26]

Aranda-Martínez P, Sayed R K A, Fernández-Martínez J, et al. Zebrafish as a human muscle model for studying age-dependent sarcopenia and frailty[J]. Int J Mol Sci, 2024, 25(11): 6166.

[27]

Ichii S, Matsuoka I, Okazaki F, et al. Zebrafish models for skeletal muscle senescence: lessons from cell cultures and rodent models[J]. Molecules, 2022, 27(23): 8625.

[28]

Rostad K O, Trognitz T, Frøyset A K, et al. Accelerated sarcopenia phenotype in the DJ-1/ Park7-knockout zebrafish[J]. Antioxidants, 2024, 13(12): 1509.

[29]

Thürkauf M, Lin S, Oliveri F, et al. Fast, multiplexable and efficient somatic gene deletions in adult mouse skeletal muscle fibers using AAV-CRISPR/ Cas9 [ J ]. Nat Commun, 2023, 14: 6116.

[30]

Elashry M I, Schneider V C, Heimann M, et al. CRISPR/ Cas9-targeted myostatin deletion improves the myogenic differentiation parameters for muscle-derived stem cells in mice[J]. J Dev Biol, 2025, 13(1): 5.

基金资助

*吉林省自然科学基金(YDZJ202401213ZYTS)

2024 年度吉林大学研究生教育教学改革与研究项目(2024JGZ028)

AI Summary AI Mindmap
PDF (1166KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉